Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
IDO | Ann: Removal from Official List - close of trading 24/8/18 | 24/08/18 | 0 | 1.4K | |||
|
|||||||
IDO | Ann: Bidder's Statement | 22/08/18 | 14 | 8.5K | |||
|
|||||||
IDO | Ann: Suspension from Official Quotation | 21/08/18 | 0 | 777 | |||
|
|||||||
IDO | Ann: Voluntary Delisting from ASX | 17/08/18 | 0 | 975 | |||
|
|||||||
IDO | Ann: Quarterly Cashflow Report | 14:41 | 0 | 736 | |||
|
|||||||
IDO | Ann: Quarterly Activities Report | 14:41 | 0 | 711 | |||
|
|||||||
IDO | News: IDO Indo Mines Says Co Resolved To Restructure PT JMI Human Resources Division To Lower... | 08/06/18 | 0 | 444 | |||
|
|||||||
IDO | Ann: Termination of JMI Employees | 08/06/18 | 0 | 1.2K | |||
|
See All Discussions